Molecular Mechanisms of Alcohol-Induced Colorectal Carcinogenesis.

Caroline H Johnson, Jaya Prakash Golla, Evangelos Dioletis, Surendra Singh, Momoko Ishii, Georgia Charkoftaki, David C Thompson, Vasilis Vasiliou
Author Information
  1. Caroline H Johnson: Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA. ORCID
  2. Jaya Prakash Golla: Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
  3. Evangelos Dioletis: Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
  4. Surendra Singh: Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
  5. Momoko Ishii: Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
  6. Georgia Charkoftaki: Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
  7. David C Thompson: Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.
  8. Vasilis Vasiliou: Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT 06520, USA.

Abstract

The etiology of colorectal cancer (CRC) is complex. Approximately, 10% of individuals with CRC have predisposing germline mutations that lead to familial cancer syndromes, whereas most CRC patients have sporadic cancer resulting from a combination of environmental and genetic risk factors. It has become increasingly clear that chronic alcohol consumption is associated with the development of sporadic CRC; however, the exact mechanisms by which alcohol contributes to colorectal carcinogenesis are largely unknown. Several proposed mechanisms from studies in CRC models suggest that alcohol metabolites and/or enzymes associated with alcohol metabolism alter cellular redox balance, cause DNA damage, and epigenetic dysregulation. In addition, alcohol metabolites can cause a dysbiotic colorectal microbiome and intestinal permeability, resulting in bacterial translocation, inflammation, and immunosuppression. All of these effects can increase the risk of developing CRC. This review aims to outline some of the most significant and recent findings on the mechanisms of alcohol in colorectal carcinogenesis. We examine the effect of alcohol on the generation of reactive oxygen species, the development of genotoxic stress, modulation of one-carbon metabolism, disruption of the microbiome, and immunosuppression.

Keywords

References

  1. World J Gastroenterol. 2016 Feb 7;22(5):1745-55 [PMID: 26855534]
  2. J Pharmacol Exp Ther. 1972 May;181(2):279-87 [PMID: 4402282]
  3. Gastroenterology. 1990 Feb;98(2):406-13 [PMID: 2295396]
  4. Front Oncol. 2016 Apr 19;6:96 [PMID: 27148488]
  5. Alcohol Res. 2015;37(2):159-70 [PMID: 26695755]
  6. JAMA Netw Open. 2020 Feb 5;3(2):e1921451 [PMID: 32083687]
  7. Mol Cancer Res. 2007 Nov;5(11):1147-57 [PMID: 18025260]
  8. Sci Rep. 2015 Jul 01;5:12044 [PMID: 26131763]
  9. Int J Mol Sci. 2017 Sep 10;18(9): [PMID: 28891965]
  10. Genes Dev. 2007 Dec 1;21(23):3110-22 [PMID: 18056424]
  11. Gastroenterology. 2003 May;124(5):1488-99 [PMID: 12730887]
  12. Am J Physiol. 1999 Apr;276(4):G965-74 [PMID: 10198341]
  13. Subcell Biochem. 2013;67:131-43 [PMID: 23400919]
  14. Biochem Biophys Res Commun. 1993 Feb 15;190(3):780-5 [PMID: 8439329]
  15. Nutr Rev. 2013 Jul;71(7):483-99 [PMID: 23815146]
  16. Nat Commun. 2019 Apr 3;10(1):1516 [PMID: 30944337]
  17. Arch Toxicol. 2009 Jun;83(6):519-48 [PMID: 19448996]
  18. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2453-9 [PMID: 19706843]
  19. Am J Epidemiol. 2012 Nov 1;176(9):751-9 [PMID: 23035019]
  20. Environ Mol Mutagen. 2014 Mar;55(2):77-91 [PMID: 24282063]
  21. Am J Clin Nutr. 2012 Oct;96(4):874-81 [PMID: 22875713]
  22. J Pharmacol Exp Ther. 2006 Apr;317(1):44-52 [PMID: 16373529]
  23. Biochemistry. 1996 Apr 9;35(14):4445-56 [PMID: 8605194]
  24. Alcohol Alcohol Suppl. 1994;2:157-62 [PMID: 8974330]
  25. Transl Res. 2007 Jun;149(6):293-7 [PMID: 17543846]
  26. J Inherit Metab Dis. 2011 Feb;34(1):3-15 [PMID: 20446114]
  27. Nat Rev Cancer. 2007 Aug;7(8):599-612 [PMID: 17646865]
  28. QJM. 2008 Nov;101(11):881-7 [PMID: 18790817]
  29. Gut. 2001 Sep;49(3):418-22 [PMID: 11511565]
  30. Alcohol Clin Exp Res. 2016 Oct;40(10):2094-2101 [PMID: 27581253]
  31. J Laryngol Otol. 2006 Nov;120(11):970-1 [PMID: 16923321]
  32. Alcohol Clin Exp Res. 2008 Jun;32(6):1049-58 [PMID: 18498552]
  33. Gut. 2002 Jan;50(1):38-42 [PMID: 11772965]
  34. Alcohol Alcohol. 2016 Jul;51(4):395-401 [PMID: 26755640]
  35. Dent Update. 1975 May-Jun;2(3):129-31 [PMID: 1073824]
  36. Int J Mol Sci. 2017 May 24;18(6): [PMID: 28538665]
  37. J Biochem. 1991 Oct;110(4):559-65 [PMID: 1778977]
  38. Nat Biotechnol. 2010 Oct;28(10):1057-68 [PMID: 20944598]
  39. Cell Metab. 2015 Jun 2;21(6):891-7 [PMID: 25959674]
  40. Cell Death Dis. 2013 Feb 21;4:e507 [PMID: 23429293]
  41. Immunotherapy. 2013 Sep;5(9):975-87 [PMID: 23998732]
  42. Alcohol. 2007 Sep;41(6):447-60 [PMID: 17869053]
  43. Lancet Public Health. 2020 Jun;5(6):e316-e323 [PMID: 32504584]
  44. Environ Microbiol. 2007 May;9(5):1101-11 [PMID: 17472627]
  45. Am J Clin Nutr. 2014 Jul;100(1):250-5 [PMID: 24808485]
  46. Cell Metab. 2016 Jul 12;24(1):104-17 [PMID: 27411012]
  47. Int J Cancer. 2004 Sep 20;111(5):711-9 [PMID: 15252840]
  48. Science. 2015 Apr 3;348(6230):80-6 [PMID: 25838377]
  49. Cell Rep. 2014 Nov 20;9(4):1507-19 [PMID: 25456139]
  50. Expert Opin Drug Metab Toxicol. 2010 Mar;6(3):307-19 [PMID: 20073996]
  51. Drug Metab Dispos. 2007 Jan;35(1):1-8 [PMID: 17020953]
  52. Cell Signal. 2017 Nov;39:18-31 [PMID: 28751279]
  53. Alcohol Res. 2015;37(2):311-22 [PMID: 26695753]
  54. Arch Pharm Res. 2000 Aug;23(4):267-82 [PMID: 10976571]
  55. Alcohol Clin Exp Res. 2011 Jul;35(7):1305-14 [PMID: 21463335]
  56. J Gastroenterol Hepatol. 2012 Sep;27(9):1423-31 [PMID: 22694276]
  57. Methods Mol Biol. 2011;682:189-205 [PMID: 21057929]
  58. Clin Gastroenterol Hepatol. 2019 Jan;17(2):275-289 [PMID: 30031175]
  59. Cancer Res. 2012 Mar 1;72(5):1092-102 [PMID: 22282655]
  60. Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18321-6 [PMID: 25489084]
  61. Tumour Biol. 2013 Aug;34(4):2389-95 [PMID: 23595220]
  62. Science. 2003 Mar 14;299(5613):1753-5 [PMID: 12637750]
  63. Pancreas. 2016 Jan;45(1):117-22 [PMID: 26566217]
  64. Genes Nutr. 2010 Jun;5(2):121-8 [PMID: 19847467]
  65. Int J Cancer. 2000 Apr 15;86(2):169-73 [PMID: 10738242]
  66. Annu Rev Physiol. 2014;76:251-74 [PMID: 24512081]
  67. Cancer. 2015 Oct 15;121(20):3684-91 [PMID: 26108676]
  68. Carcinogenesis. 2005 Jul;26(7):1285-90 [PMID: 15790587]
  69. Redox Biol. 2014;3:56-62 [PMID: 25462066]
  70. Mol Carcinog. 2012 Oct;51 Suppl 1:E151-7 [PMID: 22407825]
  71. Alcohol. 2017 Jun;61:25-31 [PMID: 28599714]
  72. Neuropsychopharmacology. 2013 Jan;38(1):23-38 [PMID: 22781841]
  73. Prev Chronic Dis. 2014 Jun 26;11:E109 [PMID: 24967831]
  74. Genomics. 2010 Apr;95(4):224-9 [PMID: 20100563]
  75. Cancer Metab. 2014 Dec 11;2:23 [PMID: 25671109]
  76. Eur J Clin Nutr. 2012 Dec;66(12):1303-8 [PMID: 23149980]
  77. Clin Liver Dis. 2012 Nov;16(4):667-85 [PMID: 23101976]
  78. Cell Cycle. 2014;13(15):2334-9 [PMID: 25483184]
  79. J Nutr. 2014 May;144(5):714-21 [PMID: 24647390]
  80. Alcohol Res. 2013;35(1):6-16 [PMID: 24313160]
  81. Toxicol Sci. 2012 Aug;128(2):427-38 [PMID: 22552773]
  82. Methods Enzymol. 2009;460:105-21 [PMID: 19446722]
  83. Arch Biochem Biophys. 2016 Aug 15;604:20-6 [PMID: 27264420]
  84. Curr Pharmacol Rep. 2017 Jun;3(3):114-125 [PMID: 28642837]
  85. J Lipid Res. 2001 Jul;42(7):1025-32 [PMID: 11441128]
  86. Mutat Res. 2000 Apr;462(2-3):55-69 [PMID: 10767618]
  87. Cancer Metab. 2014 Dec 11;2(1):27 [PMID: 25505945]
  88. J Pathol. 2017 Apr;241(5):649-660 [PMID: 28026023]
  89. Br J Nutr. 2012 Mar;107(6):800-8 [PMID: 21861943]
  90. Cancer Res. 2002 Sep 1;62(17):4992-5 [PMID: 12208751]
  91. Hepatology. 1986 Sep-Oct;6(5):1005-19 [PMID: 3019860]
  92. Proc Nutr Soc. 2006 Aug;65(3):278-90 [PMID: 16923312]
  93. BMC Cancer. 2016 Mar 07;16:189 [PMID: 26951793]
  94. Oncol Rep. 2016 Dec;36(6):3145-3153 [PMID: 27748871]
  95. J Cell Mol Med. 2016 Jun;20(6):989-93 [PMID: 27072512]
  96. Am J Gastroenterol. 2000 Dec;95(12):3374-82 [PMID: 11151864]
  97. Expert Opin Drug Metab Toxicol. 2008 Jun;4(6):697-720 [PMID: 18611112]
  98. J Neurochem. 2014 Jun;129(5):770-80 [PMID: 24521073]
  99. Lancet Oncol. 2021 Aug;22(8):1071-1080 [PMID: 34270924]
  100. Subst Abuse Rehabil. 2014 Jan 23;5:1-12 [PMID: 24648792]
  101. Mutat Res. 1988 Jan;195(1):1-20 [PMID: 3122032]
  102. Int J Cancer. 2011 Feb 1;128(3):533-40 [PMID: 20715111]
  103. Am J Clin Nutr. 2014 Dec;100(6):1479-88 [PMID: 25411283]
  104. Mol Med Rep. 2012 Apr;5(4):1063-7 [PMID: 22218715]
  105. Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034 [PMID: 20066092]
  106. Biochem Biophys Res Commun. 2011 Feb 11;405(2):173-9 [PMID: 21216231]
  107. Cell Metab. 2018 Feb 6;27(2):428-438.e5 [PMID: 29337136]
  108. Drug Metab Dispos. 2010 Oct;38(10):1679-87 [PMID: 20616185]
  109. Sci Rep. 2017 Feb 24;7:43434 [PMID: 28233834]
  110. Cancer Lett. 2015 Jan 28;356(2 Pt A):211-6 [PMID: 24569091]
  111. Cell. 2007 Sep 7;130(5):918-31 [PMID: 17803913]
  112. Br J Cancer. 2017 Nov 7;117(10):1537-1543 [PMID: 28881356]
  113. N Engl J Med. 2009 Dec 17;361(25):2449-60 [PMID: 20018966]
  114. J Nutrigenet Nutrigenomics. 2008;1(4):196-204 [PMID: 19776626]
  115. Hepatol Res. 2004 Jan;28(1):1-11 [PMID: 14734144]
  116. Life Sci. 1979 Oct 15;25(16):1443-8 [PMID: 118317]
  117. Chem Biol Interact. 2010 Dec 5;188(3):367-75 [PMID: 20813101]
  118. J Clin Pathol. 2001 May;54(5):391-5 [PMID: 11328840]
  119. Carcinogenesis. 2004 Aug;25(8):1443-8 [PMID: 15033905]
  120. Cancer Res. 2016 Apr 1;76(7):1698-704 [PMID: 26857263]
  121. Naunyn Schmiedebergs Arch Pharmacol. 1982 Jul;320(1):81-4 [PMID: 6811958]
  122. J Biomed Sci. 2017 Mar 3;24(1):19 [PMID: 28253921]
  123. Cell. 2010 Mar 19;140(6):883-99 [PMID: 20303878]
  124. Mol Carcinog. 2016 May;55(5):1002-11 [PMID: 26014148]
  125. Alcohol Clin Exp Res. 2011 Sep;35(9):1635-43 [PMID: 21535025]
  126. Cancer Sci. 2007 Sep;98(9):1439-46 [PMID: 17596206]
  127. Dis Colon Rectum. 1978 Jul-Aug;21(5):329-35 [PMID: 699722]
  128. Mol Med Rep. 2012 Apr;5(4):1027-32 [PMID: 22246134]
  129. J Biochem. 1994 Aug;116(2):321-6 [PMID: 7529759]
  130. Mol Nutr Food Res. 2013 Apr;57(4):596-606 [PMID: 23136133]

Grants

  1. K12 CA215110/NCI NIH HHS
  2. R01 AA021724/NIAAA NIH HHS
  3. UL1 TR001863/NCATS NIH HHS
  4. R24AA022057, R01AA021724,R21AA0284432-02, R21CA223686-02/NIH HHS

Word Cloud

Created with Highcharts 10.0.0alcoholCRCcolorectalcancermechanismscarcinogenesismicrobiomeimmunosuppressionsporadicresultingriskassociateddevelopmentmetabolitesmetabolismcauseDNAdamagecanstressetiologycomplexApproximately10%individualspredisposinggermlinemutationsleadfamilialsyndromeswhereaspatientscombinationenvironmentalgeneticfactorsbecomeincreasinglyclearchronicconsumptionhoweverexactcontributeslargelyunknownSeveralproposedstudiesmodelssuggestand/orenzymesaltercellularredoxbalanceepigeneticdysregulationadditiondysbioticintestinalpermeabilitybacterialtranslocationinflammationeffectsincreasedevelopingreviewaimsoutlinesignificantrecentfindingsexamineeffectgenerationreactiveoxygenspeciesgenotoxicmodulationone-carbondisruptionMolecularMechanismsAlcohol-InducedColorectalCarcinogenesisALDH1B1CYP2E1acetaldehydeoxidative

Similar Articles

Cited By